Whooping cough infection study in healthy adults
Part of Infections, Lungs & breathing clinical trials.
This study tests what happens when healthy adults are exposed to a special type of whooping cough bacteria. Results may help develop better vaccines to protect people from this infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old and in good general health.
- You have not had a pertussis (whooping cough) vaccine in the last 5 years or more than 7 total doses in your life.
- You do not have a long-term health condition like diabetes, asthma, heart disease, or a weakened immune system.
- You do not live or work closely with infants, pregnant women, elderly, or people with weak immune systems who are not up to date on their vaccines.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies children who might have pertussis (“whooping cough”). It looks at children in outpatient/home-care settings when the child’s doctor suspects pertussis and orders a lab test, to help guide evaluation and care.
This trial tests a new combined vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and how well it works to boost immunity in teens and adults.
This study looks at children with suspected pertussis (who need a PCR test) and compares how the bacteria and the immune response relate to how sick they become. It may help doctors understand why some children have worse symptoms and guide future care.
This study tests a new type of whooping cough vaccine given to pregnant women to see if it helps protect their babies from whooping cough in the first months of life. The vaccine is given during pregnancy, and then the baby's immune response is checked up to 15–18 months old.
This trial tests a new vaccine called GC3111B to see if it is safe and helps the body build protection against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy adults who have not had a similar vaccine in the last 2 years.
This study tests a lower-dose vaccine that protects against diphtheria, tetanus, and whooping cough. It aims to see if the vaccine is safe and how well it works for people aged 6 and older, possibly offering a booster with fewer side effects.
Hear when a new Pertussis (Whooping Cough) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.